Abstract
New drug delivery technologies have an important niche in treatments as they enable drugs to be more effective. Remarkably, drug delivery is still considered a poor relation to drug discovery with greater than 95% of all new potential therapeutics having poor pharmacokinetics. The greatest obstruction for cytosolic release of therapeutic molecules is the membrane barrier of target cells. The use of protein transduction domains (PTD), capable of transporting effector molecules, such as compounds, proteins and DNA, into cells has become increasingly attractive in the design of drugs as they promote the cellular uptake of cargo molecules. The PTDs are also often referred to as Trojan peptides, membrane translocating sequences or cell permeable proteins. They are generally 10-16 amino acids in length. The mechanism of internalisation remains unclear, however, recent evidence supports an energy dependant process involving endocytosis. PTDs may be grouped according to their composition, for example peptides rich in arginine and/or lysine (Tat protein from HIV-1), or secondary structure, for example α-helix (HA2 from influenza virus hemagglutinin) and β- sheet (protegrins derived from antimicrobial peptides).
Keywords: drug delivery, membrane barrier, protein transduction domain, trojan peptides, internalisation
Current Nanoscience
Title: A Closer Look at Protein Transduction Domains as a Tool in Drug Delivery
Volume: 1 Issue: 2
Author(s): Hendrik Fuchs, Christopher Bachran, Iring Heisler and Mark Sutherland
Affiliation:
Keywords: drug delivery, membrane barrier, protein transduction domain, trojan peptides, internalisation
Abstract: New drug delivery technologies have an important niche in treatments as they enable drugs to be more effective. Remarkably, drug delivery is still considered a poor relation to drug discovery with greater than 95% of all new potential therapeutics having poor pharmacokinetics. The greatest obstruction for cytosolic release of therapeutic molecules is the membrane barrier of target cells. The use of protein transduction domains (PTD), capable of transporting effector molecules, such as compounds, proteins and DNA, into cells has become increasingly attractive in the design of drugs as they promote the cellular uptake of cargo molecules. The PTDs are also often referred to as Trojan peptides, membrane translocating sequences or cell permeable proteins. They are generally 10-16 amino acids in length. The mechanism of internalisation remains unclear, however, recent evidence supports an energy dependant process involving endocytosis. PTDs may be grouped according to their composition, for example peptides rich in arginine and/or lysine (Tat protein from HIV-1), or secondary structure, for example α-helix (HA2 from influenza virus hemagglutinin) and β- sheet (protegrins derived from antimicrobial peptides).
Export Options
About this article
Cite this article as:
Fuchs Hendrik, Bachran Christopher, Heisler Iring and Sutherland Mark, A Closer Look at Protein Transduction Domains as a Tool in Drug Delivery, Current Nanoscience 2005; 1 (2) . https://dx.doi.org/10.2174/1573413054065367
DOI https://dx.doi.org/10.2174/1573413054065367 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Plant Extracts and their Secondary Metabolites as Modulators of Kinases
Current Topics in Medicinal Chemistry PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy
Current Topics in Medicinal Chemistry Ruthenium(II) Complexes as Potential Apoptosis Inducers in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Alzheimer’s Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy
Current Pharmaceutical Design Extracellular Signals for Guiding Mesenchymal Stem Cells Osteogenic Fate
Current Stem Cell Research & Therapy Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Recent Patents Relating to Tumor Suppressor Genes
Recent Patents on DNA & Gene Sequences Endothelial Lipase: A Key Player in HDL Metabolism Modulates Inflammation and Atherosclerotic Risk
Mini-Reviews in Medicinal Chemistry Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Current Drug Targets Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
Current Pharmaceutical Design Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review
Current Neuropharmacology Aloperine Induces Apoptosis by a Reactive Oxygen Species Activation Mechanism in Human Ovarian Cancer Cells
Protein & Peptide Letters Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
Current Drug Targets RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
Current Cancer Drug Targets Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets